Sino Biopharmaceutical(CH:SMZ1)
CHF 0.58+0.01 (+0.87%)
CH:SMZ1
Sino Biopharmaceutical financials statements
CHF 0.58
At close:+0.01 (+0.87%)
Sino Biopharmaceutical (SMZ1) Financial Statements
0 Followers
Sino Biopharmaceutical Financial Overview
Sino Biopharmaceutical's market cap is currently ¥10.50B. The company's EPS TTM is ¥0.13; its P/E ratio is 36.33; and it has a dividend yield of 1.87%. Sino Biopharmaceutical is estimated to report earnings on April 1, 2027, and the estimated EPS forecast is ¥0.01. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 31.83B | ¥ 28.87B | ¥ 26.20B | ¥ 26.03B | ¥ 26.86B |
| Gross Profit | ¥ 26.13B | ¥ 23.53B | ¥ 21.21B | ¥ 21.54B | ¥ 21.53B |
| Operating Income | ¥ 6.95B | ¥ 6.14B | ¥ 5.67B | ¥ 5.59B | ¥ 5.16B |
| EBITDA | ¥ 7.50B | ¥ 6.49B | ¥ 6.98B | ¥ 6.69B | ¥ 19.87B |
| Net Income | ¥ 2.34B | ¥ 3.50B | ¥ 2.33B | ¥ 2.54B | ¥ 14.61B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 22.96B | ¥ 14.60B | ¥ 14.12B | ¥ 16.92B | ¥ 15.79B |
| Total Assets | ¥ 76.04B | ¥ 65.41B | ¥ 63.60B | ¥ 64.06B | ¥ 60.54B |
| Total Debt | ¥ 16.08B | ¥ 9.78B | ¥ 12.58B | ¥ 13.98B | ¥ 12.12B |
| Net Debt | ¥ 3.90B | ¥ 214.26M | ¥ 3.13B | ¥ 5.33B | ¥ 2.52B |
| Total Liabilities | ¥ 33.92B | ¥ 22.63B | ¥ 25.43B | ¥ 26.12B | ¥ 22.81B |
| Stockholders' Equity | ¥ 30.68B | ¥ 31.96B | ¥ 30.47B | ¥ 29.75B | ¥ 30.29B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 7.59B | ¥ 5.22B | ¥ 4.36B | ¥ 4.56B | ¥ 3.47B |
| Operating Cash Flow | ¥ 9.29B | ¥ 6.62B | ¥ 6.07B | ¥ 6.27B | ¥ 5.37B |
| Investing Cash Flow | ¥ -12.41B | ¥ -1.71B | ¥ -756.98M | ¥ -4.07B | ¥ -2.52B |
| Financing Cash Flow | ¥ 4.16B | ¥ -6.32B | ¥ -6.55B | ¥ -3.19B | ¥ -3.23B |
Currency in CNY
